Evidence map›Paper›PMID 32778981›Full record

ReviewJournal of industrial microbiology & biotechnology2020

System-level understanding of gene expression and regulation for engineering secondary metabolite production in Streptomyces.

Yongjae Lee, Namil Lee, Soonkyu Hwang, Kangsan Kim, Woori Kim, Jihun Kim, Suhyung Cho, Bernhard O Palsson, Byung-Kwan Cho

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CRISPR-aided genome engineering for secondary metabolite biosynthesis in Streptomyces.Journal of industrial microbiology & biotechnology · 2024
    Review
  5. Article
  6. Genome mining for drug discovery: progress at the front end.Journal of industrial microbiology & biotechnology · 2021
    Review
  7. Clavulanic Acid Production byAntibiotics (Basel, Switzerland) · 2021
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Yongjae LeeDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Namil LeeDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Soonkyu HwangDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Kangsan KimDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Woori KimDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Jihun KimDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Suhyung ChoDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Bernhard O PalssonDepartment of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.
Byung-Kwan ChoDepartment of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea. bcho@kaist.ac.kr.ORCID http://orcid.org/0000-0003-4788-4184
Korea Advanced Institute of Science and Technology · KRIntelligent Synthetic Biology Center · KRNovo Nordisk Foundation · DK

Funding

National Research Foundation of Korea 2018M3A9F3079664Novo Nordisk Fonden NNF10CC1016517
6 · The paper itself

Abstract

The gram-positive bacterium, Streptomyces, is noticed for its ability to produce a wide array of pharmaceutically active compounds through secondary metabolism. To discover novel bioactive secondary metabolites and increase the production, Streptomyces species have been extensively studied for the past decades. Among the cellular components, RNA molecules play important roles as the messengers for gene expression and diverse regulations taking place at the RNA level. Thus, the analysis of RNA-level regulation is critical to understanding the regulation of Streptomyces' metabolism and secondary metabolite production. A dramatic advance in Streptomyces research was made recently, by exploiting high-throughput technology to systematically understand RNA levels. In this review, we describe the current status of the system-wide investigation of Streptomyces in terms of RNA, toward expansion of its genetic potential for secondary metabolite synthesis.

Indexed as

Gene Expression Regulation, BacterialStreptomycesGene ExpressionGenetic EngineeringMultigene FamilySecondary MetabolismRNASecondary metaboliteStreptomycesTranscriptionTranslation

Identifiers

PMID32778981
OpenAlexW3048064645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.